29 results
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
18 Dec 23
Virax Biolabs’ CEO James Foster Issues Letter to Shareholders
7:37am
in loss of income to the individual, increased cost to the healthcare system as well as loss of productivity to society. As a result, there is a great
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
8 Nov 23
Current report (foreign)
4:11pm
independent Director. Since October 2019, Mr. Erez has been a partner at Bain & Co., a consulting firm, focusing on private equity practice and healthcare … of McKinsey & Co., a consulting firm, focusing on private equity, healthcare and life sciences transactions, and growth strategy work for specialty pharma
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
1 Sep 23
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
7:37am
healthcare companies including Abbott Laboratories, Nigel is well equipped to execute on our growth initiatives for ViraxImmune™.” Mr. Foster continued
6-K
EX-10.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
1 Sep 23
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
7:37am
healthcare plan. The Company will pay 80% of the monthly premiums while the employee is responsible for 20% of the monthly premiums.
For UK based employment
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
18 Jul 23
Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities
7:58am
healthcare solution that is accurate, affordable and convenient,” said James Foster, Virax's Chairman of the Board of Directors and Chief Executive Officer … frontier of preventative healthcare.”
Additionally, Virax has signed a lease agreement with BioCity Glasgow to establish a research laboratory
6-K
EX-99.1
qsv17har2kbe0p
4 May 23
Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park
7:56am
424B3
ceb8v2irf m78
31 Mar 23
Prospectus supplement
4:04pm
6-K
EX-99.1
p6q9srjl934z1k97
6 Dec 22
COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States
7:40am
424B3
26iuo04is7czk0gwa4a0
2 Dec 22
Prospectus supplement
4:17pm
F-1
nkj2f lgrq
18 Nov 22
Registration statement (foreign)
5:39pm
6-K
EX-99.1
th24tp2e1 i1wh
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
6-K
EX-99.1
axpu10f
3 Nov 22
Current report (foreign)
8:03am
6-K
kacy4 ylyqs5k8uo
22 Sep 22
Current report (foreign)
8:13am
6-K
EX-99.1
ttf g9i4fuexqsmhyrk
22 Sep 22
Current report (foreign)
8:13am
6-K
EX-99.1
dk3b436im zegz26zs
20 Sep 22
Current report (foreign)
8:02am
20-F
6et36cy mhsh5fufkaz
12 Aug 22
Annual report (foreign)
4:20pm
424B4
b6v80o9y
21 Jul 22
Prospectus supplement with pricing info
10:01am
FWP
7ebp0hi6 y2mle
30 Jun 22
Free writing prospectus
9:04pm
FWP
wkm4j00d aab3l
30 Jun 22
Free writing prospectus
1:29pm